PO-1025: Prognostic factors for PFS and OS in radically treated patients with oligometastatic NSCLC. (November 2020) - LeenderS, M.; Robeers, R.; Hendriks, L.; Van Loon, J.; Bootsma, G.; Wanders, R.; Pitz, C.; Reymen, B.; Houben, R.; Van Baardwijk, A.; Verhoeven, K.; Peeters, S.; et al.